This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Nanoparticles can significantly improve the oral bioavailability of peptide drugs.
Why it matters
Improving the oral delivery of peptide drugs could lead to better patient compliance and treatment outcomes for diabetes. This research highlights innovative solutions to a common problem in drug delivery.
How the study worked
This is a review study that analyzes existing research on nanoparticles for oral peptide drug delivery.
What this study cannot tell us
As a review, it does not present new experimental data and relies on existing literature, which may vary in quality.
Read the original research
Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.
Bioactive materials, 15, 392-408
Citation
Li, Yan; Zhang, Wen; Zhao, Ruichen; Zhang, Xin. (2022). Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.. Bioactive materials, 15, 392-408. https://doi.org/10.1016/j.bioactmat.2022.02.025